ENTA
Enanta Pharmaceuticals Inc
13.00$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.9% | -5.3% | +5.4% | -18.7% | +16.1% | -12.0% | +22.7% | -17.4% | +23.1% | -7.8% | -16.3% | – | |
| – | -4.0% | -3.3% | -4.3% | -19.4% | +85.6% | +35.3% | – | – | – | – | +0.0% | – | |
| – | -4.9% | -5.3% | +5.4% | -18.7% | +16.1% | -12.0% | +22.7% | -17.4% | +23.1% | -14.3% | -10.0% | – | |
| – | +0.6% | -2.2% | -19.2% | +7.1% | -10.1% | +1.5% | -3.0% | -12.5% | -12.4% | -6.8% | +13.8% | – | |
| – | +19.7% | -13.8% | -5.8% | +2.0% | -6.1% | -11.3% | -12.2% | -3.0% | -7.1% | +6.2% | -1.0% | – | |
| – | +5.9% | -5.8% | -15.4% | +5.5% | -8.9% | -2.6% | -5.7% | -9.9% | -10.9% | -6.9% | +13.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.2% | -25.5% | -8.1% | +9.6% | -24.0% | -12.6% | -5.6% | +47.5% | +29.2% | +7.6% | +24.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +10.3% | -25.0% | -70.8% | +414.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.